one of several first direct compounds examined in vitro and in vivo in my lab has completed Phase I-IIb clinical trials, as the globe’s first pan-Bcl-2/Bcl-xL/Mcl-1 inhibitor entered clinic trials. A further XIAP inhibitor is additionally in scientific trials. Previous seminars are outlined on our archive web site. films of prior seminars may b